• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Structure Therapeutics Inc. - American Depositary Shares (NQ:GPCR)

62.77 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 174
Open 62.77
Bid (Size) 63.50 (300)
Ask (Size) 65.20 (100)
Prev. Close 62.77
Today's Range 62.77 - 62.77
52wk Range 13.22 - 94.90
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗
January 05, 2026
The development comes as attention remains on Hims’ longer-term business expansion initiatives. 
Via Stocktwits
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
As the final bells ring on Wall Street for 2025, the biotechnology sector is celebrating a dramatic reversal of fortune. After years of navigating high interest rates and regulatory uncertainty, the... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy

Performance

YTD
-7.9%
-7.9%
1 Month
-10.3%
-10.3%
3 Month
+118.9%
+118.9%
6 Month
+235.1%
+235.1%
1 Year
+128.3%
+128.3%

More News

Read More
News headline image
The Case for Small-Cap Diversification: Why Investors are Looking Beyond Mega-Cap Tech
December 23, 2025
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts
December 23, 2025
Via MarketMinute
Topics Economy
News headline image
The Great Rotation: Small-Caps Seize the Spotlight as Mega-Cap Fatigue Sets In
December 22, 2025
Via MarketMinute
Topics Economy
News headline image
The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains
December 18, 2025
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Great Rotation: Small-Caps Break Out as Russell 2000 Hits Record Highs in Late 2025
December 18, 2025
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
December 17, 2025
From Structure Therapeutics Inc.
Via GlobeNewswire
Why Did Structure Therapeutics Stock Surge Pre-Market Today? ↗
December 08, 2025
Via Stocktwits
News headline image
Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
December 11, 2025
From Structure Therapeutics Inc.
Via GlobeNewswire
News headline image
Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants
December 09, 2025
From Structure Therapeutics Inc.
Via GlobeNewswire
News headline image
Why Structure Therapeutics Stock Doubled and Then Some on Monday ↗
December 08, 2025
Via The Motley Fool
News headline image
Global Markets Brace for Fed Decision Amidst Divergent Policies and Geopolitical Crosscurrents
December 09, 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants
December 08, 2025
From Structure Therapeutics Inc.
Via GlobeNewswire
News headline image
What's going on in today's session ↗
December 08, 2025
Via Chartmill
News headline image
Wondering what's happening in today's pre-market session? ↗
December 08, 2025
Via Chartmill
News headline image
Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
December 08, 2025
From Structure Therapeutics Inc.
Via GlobeNewswire
News headline image
Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025
December 07, 2025
From Structure Therapeutics Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
November 07, 2025
Via Benzinga
News headline image
Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
November 06, 2025
From Structure Therapeutics Inc.
Via GlobeNewswire
News headline image
This Under-the-Radar Healthcare Stock Could Soar in 2026 ↗
September 12, 2025
Via The Motley Fool
News headline image
Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
September 02, 2025
From Structure Therapeutics Inc.
Via GlobeNewswire
News headline image
Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform
August 18, 2025
Via AB Newswire
Eli Lilly Stock Marks Worst Day In 25 Years As Weight-Loss Pill Data Disappoints: Analysts Divided But Retail Bets On Rebound ↗
August 07, 2025
Via Stocktwits
News headline image
Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations
August 07, 2025
Via MarketMinute
Topics Economy

Frequently Asked Questions

Is Structure Therapeutics Inc. - American Depositary Shares publicly traded?
Yes, Structure Therapeutics Inc. - American Depositary Shares is publicly traded.
What exchange does Structure Therapeutics Inc. - American Depositary Shares trade on?
Structure Therapeutics Inc. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Structure Therapeutics Inc. - American Depositary Shares?
The ticker symbol for Structure Therapeutics Inc. - American Depositary Shares is GPCR on the Nasdaq Stock Market
What is the current price of Structure Therapeutics Inc. - American Depositary Shares?
The current price of Structure Therapeutics Inc. - American Depositary Shares is 62.77
When was Structure Therapeutics Inc. - American Depositary Shares last traded?
The last trade of Structure Therapeutics Inc. - American Depositary Shares was at 01/05/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap